US92337F1075
US92337F1075
Veracyte, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 517.145.000 | 445.764.000 | 16.0% |
| Cost of Revenue | 154.613.000 | 147.619.000 | 4.7% |
| Gross Profit | 362.532.000 | 298.145.000 | 21.6% |
| 284.250.000 | 278.635.000 | 2.0% | |
| Operating Income | 78.282.000 | 19.510.000 | 301.2% |
| Pretax Income | 68.201.000 | 25.744.000 | 164.9% |
| Net Income Common Stockholders | 66.353.000 | 24.138.000 | 174.9% |
| -- | -- | -- | |
| -- | -- | -- |